Total Payments
$1,892
2023 Payments
$700.15
Companies
10
Transactions
61
Medicare Patients
3,464
Medicare Billing
$248,989
Payment Breakdown by Category
Food & Beverage$1,892 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,892 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $528.93 | 34 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $362.29 | 4 | $0 (2023) |
| Alimera Sciences, Inc. | $297.41 | 5 | $0 (2023) |
| AbbVie Inc. | $281.10 | 8 | $0 (2023) |
| Genentech, Inc. | $139.01 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $121.97 | 1 | $0 (2023) |
| Alcon Vision LLC | $112.22 | 4 | $0 (2022) |
| Alcon Laboratories Inc | $20.35 | 1 | $0 (2018) |
| NotalVision | $16.40 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $11.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $700.15 | 13 | AbbVie Inc. ($160.28) |
| 2022 | $215.44 | 5 | Regeneron Healthcare Solutions, Inc. ($94.84) |
| 2021 | $193.78 | 11 | Allergan, Inc. ($152.93) |
| 2020 | $52.21 | 4 | Allergan, Inc. ($52.21) |
| 2019 | $77.75 | 5 | Allergan Inc. ($26.66) |
| 2018 | $346.65 | 17 | Allergan Inc. ($226.30) |
| 2017 | $305.60 | 6 | Regeneron Healthcare Solutions, Inc. ($145.86) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $121.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $123.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/04/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: EYE CARE | ||||||
| 04/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: EYE CARE | ||||||
| 04/07/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: EYE CARE | ||||||
| 04/06/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: EYE CARE | ||||||
| 03/30/2023 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $68.07 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: EYE CARE | ||||||
| 03/08/2023 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $70.94 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/08/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $121.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: EYE CARE | ||||||
| 01/31/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $30.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/15/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: RETINA | ||||||
| 08/24/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $94.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/28/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $48.58 | General |
| Category: Ophthalmology | ||||||
| 03/29/2022 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: RETINA | ||||||
| 12/19/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: RETINA | ||||||
| 12/02/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: RETINA | ||||||
| 12/01/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $121.95 | General |
| Category: RETINA | ||||||
| 11/17/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: RETINA | ||||||
| 11/01/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: RETINA | ||||||
| 09/27/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: RETINA | ||||||
| 07/04/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 961 | 1,340 | $618,092 | $61,923 |
| 2022 | 7 | 738 | 1,210 | $556,963 | $51,690 |
| 2021 | 7 | 744 | 1,299 | $581,667 | $59,399 |
| 2020 | 8 | 1,021 | 1,778 | $806,508 | $75,977 |
Total Patients
3,464
Total Services
5,627
Medicare Billing
$248,989
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 146 | 164 | $84,332 | $12,877 | 15.3% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 182 | 194 | $101,050 | $11,022 | 10.9% |
| 67028 | Injection of drug into eye | Facility | 2023 | 51 | 102 | $151,173 | $7,949 | 5.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 34 | 90 | $129,522 | $7,881 | 6.1% |
| 92134 | Imaging of retina | Office | 2023 | 183 | 312 | $41,797 | $5,928 | 14.2% |
| 92134 | Imaging of retina | Facility | 2023 | 197 | 283 | $35,442 | $5,372 | 15.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 70 | 86 | $30,296 | $5,235 | 17.3% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 56 | 66 | $23,610 | $2,591 | 11.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 13 | 13 | $8,018 | $1,109 | 13.8% |
| 92004 | New patient complete exam of visual system | Facility | 2023 | 16 | 16 | $9,996 | $1,098 | 11.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 14 | $2,856 | $860.30 | 30.1% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 235 | 332 | $170,316 | $17,893 | 10.5% |
| 67028 | Injection of drug into eye | Facility | 2022 | 43 | 161 | $224,070 | $12,357 | 5.5% |
| 92134 | Imaging of retina | Facility | 2022 | 228 | 459 | $57,375 | $8,505 | 14.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 35 | 39 | $20,007 | $3,155 | 15.8% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 59 | 69 | $24,288 | $2,653 | 10.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 18 | 22 | $27,720 | $1,725 | 6.2% |
| 92004 | New patient complete exam of visual system | Facility | 2022 | 21 | 21 | $12,936 | $1,433 | 11.1% |
| 92134 | Imaging of retina | Office | 2022 | 56 | 61 | $7,945 | $1,134 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 21 | $4,221 | $1,108 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 13 | $3,861 | $878.09 | 22.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 12 | 12 | $4,224 | $849.00 | 20.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 234 | 358 | $183,654 | $18,808 | 10.2% |
| 67028 | Injection of drug into eye | Facility | 2021 | 56 | 186 | $259,875 | $13,897 | 5.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 113 | 168 | $49,896 | $12,768 | 25.6% |
About Dr. Vikram Brar, MD
Dr. Vikram Brar, MD is a Retina Specialist healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053529180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Brar, MD has received a total of $1,892 in payments from pharmaceutical and medical device companies, with $700.15 received in 2023. These payments were reported across 61 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,892).
As a Medicare-enrolled provider, Brar has provided services to 3,464 Medicare beneficiaries, totaling 5,627 services with total Medicare billing of $248,989. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Richmond, VA
- Active Since 05/21/2007
- Last Updated 06/22/2021
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1053529180
Products in Payments
- OZURDEX (Drug) $710.03
- ILUVIEN (Drug) $187.46
- EYLEA AFLIBERCEPT INJECTION (Biological) $145.86
- Vabysmo (Drug) $139.01
- ACTHAR (Biological) $121.97
- EYLEA HD (Biological) $121.59
- Iluvien (Drug) $109.95
- Centurion (Device) $103.06
- Humira (Biological) $100.00
- EYLEA (Biological) $94.84
- AcrySof IQ VIVITY IOL (Device) $29.51
- ForeseeHome (Device) $16.40
- IMBRUVICA (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Richmond
Thomas Jenkins, Md, MD
Retina Specialist — Payments: $25,259
Retina Specialist $25,259
Ali Tabassian, M.d., Ph.d, M.D., PH.D
Retina Specialist — Payments: $5,323
Retina Specialist $5,323
Juan Astruc, M.d, M.D
Retina Specialist — Payments: $4,770
Retina Specialist $4,770
John O'keefe, M.d, M.D
Retina Specialist — Payments: $4,580
Retina Specialist $4,580